Cryoport (CYRX) Financials

$5.68 -0.18 (-3.07%)

As of 01:56 PM Eastern

Annual Income Statements for Cryoport

This table shows Cryoport's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-45	-108	-123
Consolidated Net Income / (Loss)	-37	-100	-115
Net Income / (Loss) Continuing Operations	-37	-100	-115
Total Pre-Tax Income	-35	-99	-113
Total Operating Income	-32	-115	-131
Total Gross Profit	104	99	100
Total Revenue	237	233	228
Total Cost of Revenue	133	134	129
Operating Cost of Revenue	133	134	129
Total Operating Expenses	136	214	230
Selling, General & Admin Expense	120	147	149
Research & Development Expense	16	18	18
Impairment Charge	0.00	50	64
Total Other Income / (Expense), net	-3.19	16	17
Interest Expense	6.14	-0.18	-14
Interest & Investment Income	8.47	11	9.90
Other Income / (Expense), net	-5.52	5.06	-6.91
Income Tax Expense	2.24	0.24	1.28
Preferred Stock Dividends Declared	8.00	8.00	8.00
Basic Earnings per Share	($0.93)	($2.21)	($2.49)
Weighted Average Basic Shares Outstanding	48.99M	48.74M	49.35M
Diluted Earnings per Share	($0.93)	($2.21)	($2.49)
Weighted Average Diluted Shares Outstanding	48.99M	48.74M	49.35M
Weighted Average Basic & Diluted Shares Outstanding	48.34M	48.98M	49.91M

This table shows Cryoport's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-7.32	-11	-7.57	-20	-15	-64	-21	-80	-1.20	-21
Consolidated Net Income / (Loss)	-5.32	-9.44	-5.57	-18	-13	-62	-19	-78	0.81	-19
Net Income / (Loss) Continuing Operations	-5.32	-9.44	-5.57	-18	-13	-62	-19	-78	0.81	-19
Total Pre-Tax Income	-5.26	-7.96	-5.08	-18	-13	-64	-19	-78	1.45	-19
Total Operating Income	-7.80	-11	-10	-18	-17	-70	-21	-79	-16	-14
Total Gross Profit	26	26	27	25	24	23	22	25	25	27
Total Revenue	60	60	63	57	56	57	55	58	57	60
Total Cost of Revenue	34	34	36	32	32	34	33	32	31	32
Operating Cost of Revenue	34	34	36	32	32	34	33	32	31	32
Total Operating Expenses	34	37	37	43	41	93	43	104	42	41
Selling, General & Admin Expense	30	33	33	39	36	39	38	36	38	37
Research & Development Expense	3.99	4.68	3.88	4.26	5.15	4.75	4.75	4.65	4.16	4.16
Total Other Income / (Expense), net	2.54	3.08	4.96	0.61	4.11	6.12	2.60	1.62	18	-4.72
Interest Expense	1.61	1.46	1.51	1.33	-4.32	1.31	1.34	0.07	-16	0.64
Interest & Investment Income	2.49	2.68	2.47	2.65	2.85	2.62	2.60	2.81	3.06	1.43
Other Income / (Expense), net	1.67	1.86	4.01	-0.70	-3.06	4.81	1.34	-1.12	-1.62	-5.51
Income Tax Expense	0.06	1.48	0.49	0.64	0.47	-1.36	0.22	0.38	0.65	0.03
Preferred Stock Dividends Declared	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00
Basic Earnings per Share	($0.15)	($0.24)	($0.16)	($0.42)	($0.31)	($1.32)	($0.43)	($1.62)	($0.02)	($0.42)
Weighted Average Basic Shares Outstanding	48.52M	48.99M	48.36M	48.71M	48.90M	48.74M	49.02M	49.35M	49.42M	49.35M
Diluted Earnings per Share	($0.15)	($0.24)	($0.16)	($0.42)	($0.31)	($1.32)	($0.43)	($1.62)	($0.02)	($0.42)
Weighted Average Diluted Shares Outstanding	48.52M	48.99M	48.36M	48.71M	48.90M	48.74M	49.02M	49.35M	49.42M	49.35M
Weighted Average Basic & Diluted Shares Outstanding	49.00M	48.34M	45.55M	48.88M	48.96M	48.98M	49.26M	49.41M	49.43M	49.91M

This table details how cash moves in and out of Cryoport's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-103	9.75	-1.06
Net Cash From Operating Activities	-1.85	-0.76	-16
Net Cash From Continuing Operating Activities	-1.85	-0.76	-16
Net Income / (Loss) Continuing Operations	-37	-100	-115
Consolidated Net Income / (Loss)	-37	-100	-115
Depreciation Expense	23	27	31
Amortization Expense	2.58	2.53	1.94
Non-Cash Adjustments To Reconcile Net Income	42	71	76
Changes in Operating Assets and Liabilities, net	-32	-2.09	-10
Net Cash From Investing Activities	-60	36	177
Net Cash From Continuing Investing Activities	-60	36	177
Purchase of Property, Plant & Equipment	-24	-44	-20
Acquisitions	-7.17	-8.21	-1.44
Purchase of Investments	-164	-43	-51
Sale and/or Maturity of Investments	132	130	249
Other Investing Activities, net	3.00	0.98	0.00
Net Cash From Financing Activities	-39	-24	-162
Net Cash From Continuing Financing Activities	-39	-24	-162
Repayment of Debt	-3.26	-25	-164
Repurchase of Common Equity	-38	0.00	0.00
Other Financing Activities, net	2.05	1.48	2.79
Effect of Exchange Rate Changes	-1.80	-1.74	-0.02
Cash Interest Paid	3.63	3.40	2.69
Cash Income Taxes Paid	1.98	1.46	1.42

This table details how cash moves in and out of Cryoport's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	-6.31	5.87	1.94	29	-7.84	-13	3.32	-3.21	-1.79	0.62
Net Cash From Operating Activities	0.98	3.65	2.77	-4.05	-1.96	2.48	-3.27	-8.03	0.45	-5.48
Net Cash From Continuing Operating Activities	1.04	3.65	2.77	-4.05	-1.96	2.48	-3.27	-8.03	0.45	-5.48
Net Income / (Loss) Continuing Operations	-5.32	-9.44	-5.57	-18	-13	-62	-19	-78	0.81	-19
Consolidated Net Income / (Loss)	-5.32	-9.44	-5.57	-18	-13	-62	-19	-78	0.81	-19
Depreciation Expense	5.79	6.13	6.40	6.72	6.91	7.45	7.47	7.56	7.84	7.89
Amortization Expense	0.64	0.65	0.64	0.64	0.65	0.60	0.60	0.60	0.42	0.32
Non-Cash Adjustments To Reconcile Net Income	7.55	9.26	3.40	6.35	5.96	55	5.31	70	-7.30	8.30
Changes in Operating Assets and Liabilities, net	-7.62	-2.95	-2.10	0.59	-2.21	1.63	2.25	-8.07	-1.32	-3.32
Net Cash From Investing Activities	-5.87	7.12	-1.38	34	19	-15	6.45	13	154	3.48
Net Cash From Continuing Investing Activities	-5.87	7.12	-1.38	34	19	-15	6.45	13	154	3.48
Purchase of Property, Plant & Equipment	-5.59	-8.37	-10	-11	-11	-12	-4.45	-5.42	-4.93	-5.34
Acquisitions	-4.61	-0.10	-0.18	-0.21	-0.23	-7.60	-0.32	-0.35	-0.46	-0.32
Sale and/or Maturity of Investments	23	24	7.85	45	30	48	25	55	160	9.14
Net Cash From Financing Activities	-0.46	-5.31	0.07	1.15	-25	-0.13	0.51	-8.76	-155	2.01
Net Cash From Continuing Financing Activities	-0.46	-5.31	0.07	1.15	-25	-0.13	0.51	-8.76	-155	2.01
Repayment of Debt	-2.10	-1.15	-0.02	0.01	-25	-0.12	-0.11	-8.77	-155	-0.13
Other Financing Activities, net	1.00	0.45	0.09	1.14	0.25	-0.00	0.62	0.01	0.02	2.14
Effect of Exchange Rate Changes	-0.97	0.40	0.48	-2.00	0.50	-0.72	-0.38	0.26	-0.52	0.61
Cash Interest Paid	0.02	1.72	0.00	1.73	0.07	1.61	0.04	1.57	-0.98	2.06
Cash Income Taxes Paid	0.56	0.70	0.43	0.67	-0.15	0.51	0.42	0.29	0.47	0.24

This table presents Cryoport's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Total Assets	1,039	958	703
Total Current Assets	604	535	342
Cash & Equivalents	37	46	45
Short-Term Investments	487	410	216
Accounts Receivable	44	42	46
Inventories, net	28	26	22
Prepaid Expenses	9.32	10	12
Plant, Property, & Equipment, net	64	85	89
Total Noncurrent Assets	371	338	273
Goodwill	151	108	52
Intangible Assets	191	194	170
Noncurrent Deferred & Refundable Income Taxes	0.95	0.66	0.87
Other Noncurrent Operating Assets	28	34	50
Total Liabilities & Shareholders' Equity	1,039	958	703
Total Liabilities	483	469	302
Total Current Liabilities	41	46	65
Short-Term Debt	0.06	0.24	17
Accounts Payable	28	27	27
Current Deferred Revenue	0.44	1.31	1.11
Current Employee Benefit Liabilities	8.46	11	13
Other Current Liabilities	3.85	5.66	5.91
Total Noncurrent Liabilities	442	423	237
Long-Term Debt	407	380	185
Capital Lease Obligations	0.22	0.95	1.25
Noncurrent Deferred & Payable Income Tax Liabilities	4.93	2.82	2.53
Other Noncurrent Operating Liabilities	30	39	48
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	556	489	402
Total Preferred & Common Equity	556	489	402
Preferred Stock	18	26	34
Total Common Equity	538	463	368
Common Stock	1,115	1,131	1,146
Retained Earnings	-543	-642	-757
Accumulated Other Comprehensive Income / (Loss)	-35	-26	-21

This table presents Cryoport's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	1,034	1,048	1,031	1,001	943	852	702
Total Current Assets	609	605	585	549	526	502	350
Cash & Equivalents	31	39	67	59	50	46	45
Short-Term Investments	499	484	437	406	399	381	228
Accounts Receivable	44	46	43	43	41	40	43
Inventories, net	25	26	29	29	25	24	24
Prepaid Expenses	11	9.96	8.62	12	11	11	11
Plant, Property, & Equipment, net	58	71	69	75	86	87	88
Total Noncurrent Assets	367	372	376	377	331	264	263
Goodwill	147	152	149	149	108	52	54
Intangible Assets	192	188	195	193	190	178	176
Noncurrent Deferred & Refundable Income Taxes	1.64	0.94	0.93	0.86	0.76	1.58	1.67
Other Noncurrent Operating Assets	26	31	31	34	33	31	32
Total Liabilities & Shareholders' Equity	1,034	1,048	1,031	1,001	943	852	702
Total Liabilities	478	488	486	463	471	452	283
Total Current Liabilities	41	42	40	45	49	60	61
Short-Term Debt	1.01	0.06	0.06	0.07	0.11	17	18
Accounts Payable	27	26	26	28	27	25	25
Current Deferred Revenue	0.55	1.01	0.93	1.58	1.78	1.32	1.09
Current Employee Benefit Liabilities	8.63	10	8.72	10	14	11	11
Other Current Liabilities	3.10	4.20	4.43	4.95	5.66	5.66	6.30
Total Noncurrent Liabilities	437	446	446	418	422	392	222
Long-Term Debt	406	408	408	378	380	357	185
Capital Lease Obligations	23	28	0.62	30	29	1.14	1.31
Noncurrent Deferred & Payable Income Tax Liabilities	3.04	5.11	4.66	4.71	2.41	2.65	3.53
Other Noncurrent Operating Liabilities	4.60	5.14	33	4.86	10	32	32
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	556	561	544	538	472	400	419
Total Preferred & Common Equity	556	561	544	538	472	400	419
Preferred Stock	16	20	22	24	28	30	32
Total Common Equity	539	540	522	513	444	370	386
Common Stock	1,086	1,118	1,123	1,127	1,135	1,138	1,141
Retained Earnings	-504	-548	-567	-580	-661	-739	-738
Accumulated Other Comprehensive Income / (Loss)	-43	-30	-34	-34	-30	-29	-16

This table displays calculated financial ratios and metrics derived from Cryoport's official financial filings.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-
Revenue Growth	6.59%	-1.70%	-2.09%
EBITDA Growth	-1,553.67%	-562.98%	-31.20%
EBIT Growth	-81.22%	-194.18%	-25.13%
NOPAT Growth	-78.94%	-260.95%	-13.64%
Net Income Growth	86.45%	-166.75%	-15.23%
EPS Growth	84.95%	-137.63%	-12.67%
Operating Cash Flow Growth	-122.78%	59.10%	-2,056.27%
Free Cash Flow Firm Growth	-75.48%	-23.25%	59.47%
Invested Capital Growth	5.16%	-6.03%	-16.86%
Revenue Q/Q Growth	1.68%	-1.31%	1.00%
EBITDA Q/Q Growth	11.17%	-214.40%	30.35%
EBIT Q/Q Growth	1.41%	-103.05%	24.87%
NOPAT Q/Q Growth	-9.14%	-104.47%	29.95%
Net Income Q/Q Growth	87.04%	-113.55%	27.58%
EPS Q/Q Growth	85.47%	-95.58%	26.55%
Operating Cash Flow Q/Q Growth	35.97%	-282.41%	-95.23%
Free Cash Flow Firm Q/Q Growth	6.15%	13.98%	-72,519.87%
Invested Capital Q/Q Growth	-3.73%	-13.95%	-1.71%
Profitability Metrics	-	-	-
Gross Margin	43.78%	42.59%	43.62%
EBITDA Margin	-5.09%	-34.34%	-46.01%
Operating Margin	-13.45%	-49.37%	-57.30%
EBIT Margin	-15.77%	-47.20%	-60.32%
Profit (Net Income) Margin	-15.73%	-42.69%	-50.25%
Tax Burden Percent	106.38%	100.24%	101.12%
Interest Burden Percent	93.77%	90.23%	82.37%
Effective Tax Rate	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-5.20%	-18.90%	-24.20%
ROIC Less NNEP Spread (ROIC-NNEP)	3.63%	0.91%	10.38%
Return on Net Nonoperating Assets (RNNOA)	-1.03%	-0.17%	-1.56%
Return on Equity (ROE)	-6.23%	-19.06%	-25.76%
Cash Return on Invested Capital (CROIC)	-10.23%	-12.68%	-5.79%
Operating Return on Assets (OROA)	-3.48%	-11.03%	-16.59%
Return on Assets (ROA)	-3.47%	-9.98%	-13.82%
Return on Common Equity (ROCE)	-6.09%	-18.25%	-24.01%
Return on Equity Simple (ROE_SIMPLE)	-6.72%	-20.36%	-28.55%
Net Operating Profit after Tax (NOPAT)	-22	-81	-92
NOPAT Margin	-9.41%	-34.56%	-40.11%
Net Nonoperating Expense Percent (NNEP)	-8.84%	-19.80%	-34.58%
Return On Investment Capital (ROIC_SIMPLE)	-2.32%	-9.26%	-15.13%
Cost of Revenue to Revenue	56.22%	57.41%	56.38%
SG&A Expenses to Revenue	50.60%	62.97%	65.23%
R&D to Revenue	6.63%	7.73%	7.75%
Operating Expenses to Revenue	57.22%	91.95%	100.92%
Earnings before Interest and Taxes (EBIT)	-37	-110	-138
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-12	-80	-105
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	1.58	1.64	1.05
Price to Tangible Book Value (P/TBV)	4.35	4.74	2.64
Price to Revenue (P/Rev)	3.58	3.25	1.68
Price to Earnings (P/E)	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.71	1.72	1.05
Enterprise Value to Revenue (EV/Rev)	3.17	3.04	1.58
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	0.73	0.78	0.51
Long-Term Debt to Equity	0.73	0.78	0.46
Financial Leverage	-0.28	-0.18	-0.15
Leverage Ratio	1.80	1.91	1.86
Compound Leverage Factor	1.68	1.72	1.54
Debt to Total Capital	42.29%	43.80%	33.62%
Short-Term Debt to Total Capital	0.01%	0.03%	2.85%
Long-Term Debt to Total Capital	42.29%	43.77%	30.77%
Preferred Equity to Total Capital	1.90%	3.02%	5.66%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	55.81%	53.18%	60.72%
Debt to EBITDA	-33.72	-4.76	-1.94
Net Debt to EBITDA	9.60	0.94	0.55
Long-Term Debt to EBITDA	-33.72	-4.76	-1.77
Debt to NOPAT	-18.24	-4.73	-2.22
Net Debt to NOPAT	5.19	0.94	0.64
Long-Term Debt to NOPAT	-18.24	-4.72	-2.03
Altman Z-Score	1.09	0.51	-0.59
Noncontrolling Interest Sharing Ratio	2.38%	4.26%	6.80%
Liquidity Ratios	-	-	-
Current Ratio	14.79	11.73	5.29
Quick Ratio	13.88	10.94	4.76
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-44	-54	-22
Operating Cash Flow to CapEx	-7.85%	-1.72%	-81.05%
Free Cash Flow to Firm to Interest Expense	-7.15	0.00	0.00
Operating Cash Flow to Interest Expense	-0.30	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	-4.14	0.00	0.00
Efficiency Ratios	-	-	-
Asset Turnover	0.22	0.23	0.28
Accounts Receivable Turnover	5.70	5.43	5.20
Inventory Turnover	6.04	4.97	5.29
Fixed Asset Turnover	4.21	3.14	2.63
Accounts Payable Turnover	4.71	4.87	4.75
Days Sales Outstanding (DSO)	64.05	67.23	70.20
Days Inventory Outstanding (DIO)	60.44	73.43	68.99
Days Payable Outstanding (DPO)	77.47	75.01	76.83
Cash Conversion Cycle (CCC)	47.01	65.66	62.37
Capital & Investment Metrics	-	-	-
Invested Capital	440	413	344
Invested Capital Turnover	0.55	0.55	0.60
Increase / (Decrease) in Invested Capital	22	-27	-70
Enterprise Value (EV)	752	709	361
Market Capitalization	850	758	385
Book Value per Share	$10.97	$9.45	$7.44
Tangible Book Value per Share	$3.99	$3.27	$2.94
Total Capital	963	870	605
Total Debt	407	381	204
Total Long-Term Debt	407	381	186
Net Debt	-116	-76	-58
Capital Expenditures (CapEx)	24	44	20
Debt-free, Cash-free Net Working Capital (DFCFNWC)	40	33	33
Debt-free Net Working Capital (DFNWC)	563	490	294
Net Working Capital (NWC)	563	490	277
Net Nonoperating Expense (NNE)	15	19	23
Net Nonoperating Obligations (NNO)	-116	-76	-58
Total Depreciation and Amortization (D&A)	25	30	33
Debt-free, Cash-free Net Working Capital to Revenue	16.88%	14.14%	14.23%
Debt-free Net Working Capital to Revenue	237.44%	209.96%	128.84%
Net Working Capital to Revenue	237.41%	209.86%	121.29%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($0.93)	($2.21)	($2.49)
Adjusted Weighted Average Basic Shares Outstanding	48.99M	48.74M	49.35M
Adjusted Diluted Earnings per Share	($0.93)	($2.21)	($2.49)
Adjusted Weighted Average Diluted Shares Outstanding	48.99M	48.74M	49.35M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	48.34M	48.98M	49.91M
Normalized Net Operating Profit after Tax (NOPAT)	-22	-46	-47
Normalized NOPAT Margin	-9.41%	-19.68%	-20.55%
Pre Tax Income Margin	-14.79%	-42.59%	-49.69%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	-6.09	0.00	0.00
NOPAT to Interest Expense	-3.64	0.00	0.00
EBIT Less CapEx to Interest Expense	-9.93	0.00	0.00
NOPAT Less CapEx to Interest Expense	-7.48	0.00	0.00
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	-101.68%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Cryoport's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	6.65%	6.94%	20.10%	-11.12%	-7.12%	-5.13%	-13.09%	1.01%	0.90%	3.97%
EBITDA Growth	26.61%	38.81%	114.72%	-270.27%	-4,307.46%	-2,280.38%	-1,281.29%	-518.58%	21.19%	80.31%
EBIT Growth	-18.80%	5.53%	52.94%	-105.24%	-225.48%	-608.68%	-230.17%	-322.09%	9.65%	70.12%
NOPAT Growth	-70.52%	-31.95%	-28.47%	-249.38%	-116.70%	-533.18%	-111.86%	-332.18%	23.17%	80.06%
Net Income Growth	18.54%	96.37%	58.42%	-100.01%	-149.61%	-561.18%	-238.98%	-324.89%	106.07%	70.06%
EPS Growth	16.67%	95.80%	48.39%	-82.61%	-106.67%	-450.00%	-168.75%	-285.71%	93.55%	68.18%
Operating Cash Flow Growth	-88.94%	39.79%	429.39%	42.18%	-299.49%	-32.07%	-217.70%	-97.95%	122.82%	-320.79%
Free Cash Flow Firm Growth	92.16%	-59.28%	-279.07%	-174.88%	-11.13%	23.51%	152.33%	221.72%	444.47%	367.43%
Invested Capital Growth	6.11%	5.16%	9.84%	5.63%	5.14%	-6.03%	-8.61%	-22.33%	-27.21%	-16.86%
Revenue Q/Q Growth	-5.75%	-0.18%	4.07%	-9.23%	-1.52%	1.96%	-4.66%	5.50%	-1.62%	5.06%
EBITDA Q/Q Growth	109.36%	-911.86%	141.96%	-1,261.29%	-6.35%	-359.31%	79.18%	-508.10%	86.45%	-14.77%
EBIT Q/Q Growth	33.85%	-49.63%	34.20%	-215.17%	-4.90%	-225.81%	69.35%	-302.91%	77.55%	-7.74%
NOPAT Q/Q Growth	-48.71%	-41.42%	8.97%	-82.50%	7.76%	-313.22%	69.54%	-272.29%	83.60%	-7.23%
Net Income Q/Q Growth	42.07%	-77.50%	40.93%	-229.30%	27.71%	-370.19%	69.71%	-312.75%	101.03%	-2,420.12%
EPS Q/Q Growth	34.78%	-60.00%	33.33%	-162.50%	26.19%	-325.81%	67.42%	-276.74%	98.77%	-2,000.00%
Operating Cash Flow Q/Q Growth	114.01%	272.10%	-24.08%	-246.14%	51.68%	226.70%	-231.55%	-145.79%	105.57%	-1,325.95%
Free Cash Flow Firm Q/Q Growth	-137.73%	7.82%	-68.93%	25.75%	3.89%	36.55%	215.57%	72.70%	171.98%	-50.74%
Invested Capital Q/Q Growth	7.59%	-3.73%	7.70%	-5.30%	7.08%	-13.95%	4.74%	-19.52%	0.35%	-1.71%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	43.69%	43.54%	43.10%	43.38%	43.21%	40.62%	39.89%	43.73%	44.80%	45.83%
EBITDA Margin	0.49%	-3.97%	1.60%	-20.47%	-22.10%	-99.56%	-21.75%	-125.34%	-17.26%	-18.86%
Operating Margin	-12.91%	-18.28%	-15.99%	-32.15%	-30.11%	-122.02%	-38.98%	-137.56%	-28.99%	-23.40%
EBIT Margin	-10.15%	-15.21%	-9.62%	-33.38%	-35.56%	-113.62%	-36.53%	-139.50%	-31.84%	-32.65%
Profit (Net Income) Margin	-8.79%	-15.63%	-8.87%	-32.19%	-23.63%	-108.96%	-34.61%	-135.40%	1.42%	-31.37%
Tax Burden Percent	101.08%	118.56%	109.68%	103.58%	103.68%	97.87%	101.15%	100.49%	55.36%	100.16%
Interest Burden Percent	85.72%	86.70%	84.14%	93.09%	64.09%	97.99%	93.67%	96.59%	-8.06%	95.93%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	44.64%	0.00%
Return on Invested Capital (ROIC)	-4.75%	-7.08%	-6.13%	-12.40%	-10.63%	-46.70%	-13.55%	-54.51%	-8.74%	-9.88%
ROIC Less NNEP Spread (ROIC-NNEP)	-4.84%	-6.07%	-7.23%	-7.79%	-8.79%	-32.64%	-7.20%	-23.93%	-24.45%	3.45%
Return on Net Nonoperating Assets (RNNOA)	1.27%	1.72%	1.64%	1.68%	1.25%	5.99%	0.88%	3.73%	3.22%	-0.52%
Return on Equity (ROE)	-3.48%	-5.36%	-4.49%	-10.73%	-9.38%	-40.72%	-12.67%	-50.78%	-5.52%	-10.40%
Cash Return on Invested Capital (CROIC)	-10.54%	-10.23%	-14.66%	-13.04%	-13.42%	-12.68%	-10.52%	-7.76%	-0.01%	-5.79%
Operating Return on Assets (OROA)	-2.55%	-3.35%	-2.24%	-7.74%	-8.26%	-26.55%	-8.26%	-33.43%	-8.46%	-8.98%
Return on Assets (ROA)	-2.21%	-3.45%	-2.07%	-7.46%	-5.49%	-25.46%	-7.82%	-32.45%	0.38%	-8.63%
Return on Common Equity (ROCE)	-3.41%	-5.23%	-4.37%	-10.38%	-9.03%	-38.98%	-12.07%	-47.95%	-5.19%	-9.69%
Return on Equity Simple (ROE_SIMPLE)	-51.82%	0.00%	-5.26%	-7.11%	-8.68%	0.00%	-23.91%	-43.13%	-37.86%	0.00%
Net Operating Profit after Tax (NOPAT)	-5.46	-7.72	-7.03	-13	-12	-49	-15	-55	-9.09	-9.75
NOPAT Margin	-9.03%	-12.80%	-11.19%	-22.50%	-21.08%	-85.42%	-27.29%	-96.29%	-16.05%	-16.38%
Net Nonoperating Expense Percent (NNEP)	0.09%	-1.01%	1.10%	-4.61%	-1.84%	-14.07%	-6.34%	-30.59%	15.71%	-13.33%
Return On Investment Capital (ROIC_SIMPLE)	-0.55%	-0.80%	-0.71%	-1.35%	-1.25%	-5.62%	-1.69%	-7.15%	-1.46%	-1.61%
Cost of Revenue to Revenue	56.31%	56.46%	56.90%	56.62%	56.79%	59.38%	60.11%	56.27%	55.20%	54.17%
SG&A Expenses to Revenue	50.01%	54.07%	52.92%	68.05%	64.15%	67.79%	70.16%	62.44%	66.45%	62.25%
R&D to Revenue	6.59%	7.75%	6.17%	7.48%	9.17%	8.29%	8.70%	8.07%	7.34%	6.98%
Operating Expenses to Revenue	56.60%	61.82%	59.09%	75.52%	73.32%	162.65%	78.87%	181.29%	73.79%	69.23%
Earnings before Interest and Taxes (EBIT)	-6.14	-9.18	-6.04	-19	-20	-65	-20	-80	-18	-19
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	0.30	-2.40	1.01	-12	-12	-57	-12	-72	-9.78	-11
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.19	1.58	2.15	1.51	1.31	1.64	1.95	0.92	1.04	1.05
Price to Tangible Book Value (P/TBV)	5.91	4.35	5.79	4.42	3.91	4.74	5.93	2.45	2.56	2.64
Price to Revenue (P/Rev)	5.06	3.58	4.68	3.26	2.84	3.25	3.85	1.51	1.77	1.68
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.40	1.71	2.31	1.59	1.33	1.72	1.98	0.92	1.04	1.05
Enterprise Value to Revenue (EV/Rev)	4.71	3.17	4.41	2.96	2.70	3.04	3.80	1.41	1.61	1.58
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	2,740.69	212.24	1,535.58	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.78	0.73	0.78	0.75	0.76	0.78	0.87	0.94	0.49	0.51
Long-Term Debt to Equity	0.77	0.73	0.78	0.75	0.76	0.78	0.87	0.89	0.44	0.46
Financial Leverage	-0.26	-0.28	-0.23	-0.22	-0.14	-0.18	-0.12	-0.16	-0.13	-0.15
Leverage Ratio	1.54	1.80	1.82	1.87	1.86	1.91	1.93	1.99	1.78	1.86
Compound Leverage Factor	1.32	1.56	1.53	1.74	1.19	1.87	1.81	1.93	-0.14	1.79
Debt to Total Capital	43.66%	42.29%	43.74%	42.91%	43.19%	43.80%	46.43%	48.41%	32.74%	33.62%
Short-Term Debt to Total Capital	0.10%	0.01%	0.01%	0.01%	0.01%	0.03%	0.01%	2.24%	2.82%	2.85%
Long-Term Debt to Total Capital	43.56%	42.29%	43.74%	42.90%	43.19%	43.77%	46.42%	46.17%	29.92%	30.77%
Preferred Equity to Total Capital	1.65%	1.90%	2.04%	2.34%	2.57%	3.02%	3.21%	3.90%	5.19%	5.66%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	54.69%	55.81%	54.22%	54.76%	54.24%	53.18%	50.36%	47.68%	62.07%	60.72%
Debt to EBITDA	-31.67	-33.72	-102.62	-32.04	-16.05	-4.76	-4.40	-2.45	-1.35	-1.94
Net Debt to EBITDA	7.27	9.60	20.44	7.49	2.24	0.94	0.42	0.34	0.46	0.55
Long-Term Debt to EBITDA	-31.60	-33.72	-102.60	-32.04	-16.04	-4.76	-4.40	-2.33	-1.23	-1.77
Debt to NOPAT	-21.05	-18.24	-18.24	-12.38	-10.37	-4.73	-4.63	-2.86	-1.56	-2.22
Net Debt to NOPAT	4.83	5.19	3.63	2.89	1.45	0.94	0.44	0.39	0.53	0.64
Long-Term Debt to NOPAT	-21.00	-18.24	-18.24	-12.37	-10.37	-4.72	-4.62	-2.73	-1.42	-2.03
Altman Z-Score	1.67	1.17	1.56	1.01	0.83	0.66	0.90	-0.19	0.11	-0.04
Noncontrolling Interest Sharing Ratio	2.04%	2.38%	2.78%	3.28%	3.71%	4.26%	4.70%	5.56%	5.91%	6.80%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	14.96	14.79	14.54	14.54	12.23	11.73	10.73	8.38	5.70	5.29
Quick Ratio	14.09	13.88	13.66	13.61	11.32	10.94	10.00	7.80	5.15	4.76
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-32	-29	-49	-37	-35	-22	26	45	122	60
Operating Cash Flow to CapEx	17.56%	43.67%	27.65%	-37.73%	-17.39%	20.71%	-73.39%	-148.04%	9.07%	-102.54%
Free Cash Flow to Firm to Interest Expense	-19.75	-20.12	-32.79	-27.61	0.00	-17.16	19.35	677.63	0.00	94.22
Operating Cash Flow to Interest Expense	0.61	2.51	1.84	-3.05	0.00	1.90	-2.44	-121.59	0.00	-8.62
Operating Cash Flow Less CapEx to Interest Expense	-2.86	-3.24	-4.81	-11.12	0.00	-7.28	-5.77	-203.73	0.00	-17.02
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.25	0.22	0.23	0.23	0.23	0.23	0.23	0.24	0.27	0.28
Accounts Receivable Turnover	5.63	5.70	6.09	5.53	5.43	5.43	5.18	5.42	5.25	5.20
Inventory Turnover	6.98	6.04	5.73	5.25	5.00	4.97	5.09	5.00	4.96	5.29
Fixed Asset Turnover	4.64	4.21	4.06	3.91	3.58	3.14	2.86	2.90	2.78	2.63
Accounts Payable Turnover	4.68	4.71	5.14	4.76	4.85	4.87	4.92	5.15	4.92	4.75
Days Sales Outstanding (DSO)	64.82	64.05	59.96	65.96	67.21	67.23	70.42	67.33	69.48	70.20
Days Inventory Outstanding (DIO)	52.32	60.44	63.66	69.55	73.06	73.43	71.76	72.98	73.64	68.99
Days Payable Outstanding (DPO)	77.97	77.47	71.03	76.68	75.33	75.01	74.17	70.89	74.21	76.83
Cash Conversion Cycle (CCC)	39.16	47.01	52.59	58.83	64.94	65.66	68.01	69.42	68.90	62.37
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	457	440	474	449	480	413	433	348	350	344
Invested Capital Turnover	0.53	0.55	0.55	0.55	0.50	0.55	0.50	0.57	0.54	0.60
Increase / (Decrease) in Invested Capital	26	22	42	24	23	-27	-41	-100	-131	-70
Enterprise Value (EV)	1,099	752	1,094	712	637	709	856	319	364	361
Market Capitalization	1,181	850	1,160	786	670	758	867	340	401	385
Book Value per Share	$11.12	$10.97	$11.18	$11.46	$10.50	$9.45	$9.06	$7.51	$7.82	$7.44
Tangible Book Value per Share	$4.12	$3.99	$4.15	$3.90	$3.51	$3.27	$2.99	$2.82	$3.17	$2.94
Total Capital	986	963	996	953	946	870	881	776	622	605
Total Debt	431	407	436	409	409	381	409	375	204	204
Total Long-Term Debt	430	407	436	409	409	381	409	358	186	186
Net Debt	-99	-116	-87	-96	-57	-76	-39	-52	-69	-58
Capital Expenditures (CapEx)	5.59	8.37	10	11	11	12	4.45	5.42	4.93	5.34
Debt-free, Cash-free Net Working Capital (DFCFNWC)	40	40	40	40	38	33	28	32	34	33
Debt-free Net Working Capital (DFNWC)	569	563	563	545	504	490	477	460	306	294
Net Working Capital (NWC)	568	563	563	545	504	490	477	442	289	277
Net Nonoperating Expense (NNE)	-0.15	1.71	-1.46	5.52	1.43	13	4.00	23	-9.90	8.93
Net Nonoperating Obligations (NNO)	-99	-116	-87	-96	-57	-76	-39	-52	-69	-58
Total Depreciation and Amortization (D&A)	6.43	6.79	7.05	7.37	7.56	8.05	8.07	8.16	8.26	8.21
Debt-free, Cash-free Net Working Capital to Revenue	17.09%	16.88%	16.34%	16.75%	16.27%	14.14%	12.57%	14.35%	14.95%	14.23%
Debt-free Net Working Capital to Revenue	244.00%	237.44%	227.25%	226.46%	213.37%	209.96%	211.90%	203.68%	135.54%	128.84%
Net Working Capital to Revenue	243.57%	237.41%	227.23%	226.43%	213.34%	209.86%	211.85%	195.96%	127.77%	121.29%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.15)	($0.24)	($0.16)	($0.42)	($0.31)	($1.32)	($0.43)	($1.62)	($0.02)	($0.42)
Adjusted Weighted Average Basic Shares Outstanding	48.52M	48.99M	48.36M	48.71M	48.90M	48.74M	49.02M	49.35M	49.42M	49.35M
Adjusted Diluted Earnings per Share	($0.15)	($0.24)	($0.16)	($0.42)	($0.31)	($1.32)	($0.43)	($1.62)	($0.02)	($0.42)
Adjusted Weighted Average Diluted Shares Outstanding	48.52M	48.99M	48.36M	48.71M	48.90M	48.74M	49.02M	49.35M	49.42M	49.35M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	49.00M	48.34M	45.55M	48.88M	48.96M	48.98M	49.26M	49.41M	49.43M	49.91M
Normalized Net Operating Profit after Tax (NOPAT)	-5.46	-7.72	-7.03	-13	-12	-14	-15	-11	-9.09	-9.75
Normalized NOPAT Margin	-9.03%	-12.80%	-11.19%	-22.50%	-21.08%	-24.82%	-27.29%	-18.74%	-16.05%	-16.38%
Pre Tax Income Margin	-8.70%	-13.19%	-8.09%	-31.08%	-22.79%	-111.33%	-34.22%	-134.74%	2.57%	-31.32%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-3.81	-6.30	-4.00	-14.30	0.00	-49.81	-14.90	-1,217.41	0.00	-30.56
NOPAT to Interest Expense	-3.39	-5.31	-4.66	-9.64	0.00	-37.45	-11.13	-840.30	0.00	-15.33
EBIT Less CapEx to Interest Expense	-7.29	-12.05	-10.65	-22.37	0.00	-58.99	-18.23	-1,299.55	0.00	-38.97
NOPAT Less CapEx to Interest Expense	-6.87	-11.05	-11.31	-17.71	0.00	-46.63	-14.46	-922.43	0.00	-23.74
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-11.58%	-101.68%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Cryoport's Financials

When does Cryoport's financial year end?

According to the most recent income statement we have on file, Cryoport's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Cryoport's net income changed over the last 2 years?

Cryoport's net income appears to be on an upward trend, with a most recent value of -$114.76 million in 2024, rising from -$37.33 million in 2022. The previous period was -$99.59 million in 2023. See where experts think Cryoport is headed by visiting Cryoport's forecast page.

What is Cryoport's operating income?

Cryoport's total operating income in 2024 was -$130.87 million, based on the following breakdown:

Total Gross Profit: $99.63 million
Total Operating Expenses: $230.50 million

How has Cryoport revenue changed over the last 2 years?

Over the last 2 years, Cryoport's total revenue changed from $237.28 million in 2022 to $228.39 million in 2024, a change of -3.7%.

How much debt does Cryoport have?

Cryoport's total liabilities were at $301.59 million at the end of 2024, a 35.7% decrease from 2023, and a 37.5% decrease since 2022.

How much cash does Cryoport have?

In the past 2 years, Cryoport's cash and equivalents has ranged from $36.60 million in 2022 to $46.35 million in 2023, and is currently $45.29 million as of their latest financial filing in 2024.

How has Cryoport's book value per share changed over the last 2 years?

Over the last 2 years, Cryoport's book value per share changed from 10.97 in 2022 to 7.44 in 2024, a change of -32.2%.

Related Companies

This page (NASDAQ:CYRX) was last updated on 5/5/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cryoport (CYRX) Financials

Frequently Asked Questions About Cryoport's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cryoport (CYRX) Financials

Annual Income Statements for Cryoport

Quarterly Income Statements for Cryoport

Annual Cash Flow Statements for Cryoport

Quarterly Cash Flow Statements for Cryoport

Annual Balance Sheets for Cryoport

Quarterly Balance Sheets for Cryoport

Annual Metrics and Ratios for Cryoport

Quarterly Metrics and Ratios for Cryoport

Frequently Asked Questions About Cryoport's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools